240 related articles for article (PubMed ID: 3535866)
1. Scl 70 antibody--a specific marker of systemic sclerosis.
Jarzabek-Chorzelska M; Blaszczyk M; Jablonska S; Chorzelski T; Kumar V; Beutner EH
Br J Dermatol; 1986 Oct; 115(4):393-401. PubMed ID: 3535866
[TBL] [Abstract][Full Text] [Related]
2. Immunological markers of the subsets of systemic scleroderma and its overlap.
Jabłońska S; Błaszczyk M; Jarzabek-Chorzelska M; Chorzelski T; Kołacińska-Strasz Z
Arch Immunol Ther Exp (Warsz); 1991; 39(4):381-90. PubMed ID: 1821614
[TBL] [Abstract][Full Text] [Related]
3. Anticentromere antibody: an immunological marker of a subset of systemic sclerosis.
Chorzelski TP; Jablonska S; Beutner EH; Blaszczyk M; Jarzabek-Chorzelska M; Kencka D; Krasny S; Kumar V; Tchórzewska A
Br J Dermatol; 1985 Oct; 113(4):381-9. PubMed ID: 3877519
[TBL] [Abstract][Full Text] [Related]
4. [Nuclear antibodies as serologic markers in progressive systemic scleroderma].
Lakomek HJ; Guldner HH; Bautz FA; Goerz G; Kind P; Mensing H; Krüskemper HL
Hautarzt; 1987 Feb; 38(2):63-9. PubMed ID: 3106261
[TBL] [Abstract][Full Text] [Related]
5. Clinical subsets of scleroderma: relevance of fluorescent and precipitating antinuclear antibodies.
Cassani F; Tosti A; Bianchi FB; Fusconi M; Selleri L; Baffoni L; Veronesi S; Volta U; Lenzi M; Pisi E
Clin Exp Rheumatol; 1987; 5(1):23-8. PubMed ID: 3109797
[TBL] [Abstract][Full Text] [Related]
6. Antinuclear antibodies in progressive systemic sclerosis.
Riboldi P; Asero R; Origgi L; Crespi S; Meroni PL; Sguotti C; Sabbadini MG
Clin Exp Rheumatol; 1985; 3(3):205-11. PubMed ID: 3902296
[TBL] [Abstract][Full Text] [Related]
7. Anticentromere antibody in localized scleroderma.
Ruffatti A; Peserico A; Glorioso S; Fiocco U; Rossi L; Gambari P; Todesco S
J Am Acad Dermatol; 1986 Oct; 15(4 Pt 1):637-42. PubMed ID: 3534010
[TBL] [Abstract][Full Text] [Related]
8. Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome.
Tan EM; Rodnan GP; Garcia I; Moroi Y; Fritzler MJ; Peebles C
Arthritis Rheum; 1980 Jun; 23(6):617-25. PubMed ID: 6155920
[TBL] [Abstract][Full Text] [Related]
9. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
[TBL] [Abstract][Full Text] [Related]
10. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis.
Bunn CC; Denton CP; Shi-Wen X; Knight C; Black CM
Br J Rheumatol; 1998 Jan; 37(1):15-20. PubMed ID: 9487245
[TBL] [Abstract][Full Text] [Related]
11. [Anti-Scl-70 antibodies in systemic scleroderma].
Le Thi Huong ; Sauvaget F; Johanet C; De Gennes C; Raguin G; Abuaf N; Blétry O; Guillevin L; Homberg JC; Godeau P
Ann Dermatol Venereol; 1990; 117(2):103-7. PubMed ID: 2111650
[TBL] [Abstract][Full Text] [Related]
12. [The PM-Scl (polymyositis-scleroderma) autoantibody and its nucleolar fluorescence pattern].
Kühn G; Jarzabek-Chorzelska M; Blaszczyk M; Kolacinska-Strasz Z; Chorzelski TP; Jablonska S
Dermatol Monatsschr; 1989; 175(8):479-83. PubMed ID: 2676628
[TBL] [Abstract][Full Text] [Related]
13. Serological markers in progressive systemic sclerosis: clinical correlations.
Catoggio LJ; Bernstein RM; Black CM; Hughes GR; Maddison PJ
Ann Rheum Dis; 1983 Feb; 42(1):23-7. PubMed ID: 6402991
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of methods for detection of anticentromere antibodies and other antinuclear antibodies.
Beutner EH; Krasny SA; Chorzelski TP; Rodnan G; Jablonska S; Kumar V
J Am Acad Dermatol; 1985 Feb; 12(2 Pt 1):289-95. PubMed ID: 3882784
[TBL] [Abstract][Full Text] [Related]
15. Frequency and clinical significance of anticentromere and anti Scl-70 antibodies in an English connective tissue disease population.
Catoggio LJ; Skinner RP; Maddison PJ
Rheumatol Int; 1983; 3(1):19-21. PubMed ID: 6412349
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of antinuclear antibodies in progressive systemic sclerosis].
Scagliusi P; De Lucia M; Di Luca ML; Pannarale M; Pipitone V
Minerva Med; 1984 Feb; 75(5):161-6. PubMed ID: 6366619
[TBL] [Abstract][Full Text] [Related]
17. [Centromere antibodies and antibodies against Scl 70 nucleoprotein in progressive systemic scleroderma. Diagnostic and prognostic significance].
Meurer M; Scharf A; Luderschmidt C; Braun-Falco O
Dtsch Med Wochenschr; 1985 Jan; 110(1):8-14. PubMed ID: 3880700
[TBL] [Abstract][Full Text] [Related]
18. Antinuclear antibodies in the relatives of patients with systemic sclerosis.
Takehara K; Moroi Y; Ishibashi Y
Br J Dermatol; 1985 Jan; 112(1):23-33. PubMed ID: 3918553
[TBL] [Abstract][Full Text] [Related]
19. [The Scl-70 antibody and its clinical significance].
Kühn G; Jarzabek-Chorzelska M; Blaszczyk M; Kolacinska-Strasz Z; Chorzelski TP; Jablonska S
Dermatol Monatsschr; 1989; 175(3):133-47. PubMed ID: 2653887
[TBL] [Abstract][Full Text] [Related]
20. Antikinetochore and antitopoisomerase I antibodies in systemic scleroderma: comparative study using immunoblotted recombinant antigens, immunofluorescence, and double immunodiffusion.
Jarzabek-Chorzelska M; Blaszczyk M; Kolacinska-Strasz Z; Chorzelski T; Jabłońska S; Maul GG
Arch Dermatol Res; 1990; 282(2):76-83. PubMed ID: 2162156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
